helically-cut strips of cerebral arteries isolated from dogs, serotonin, try ptamine, 5-hydroxytryptophan and tryptophan caused a dose-related contraction. The potency was in the order of serotonin>tryptamine >5-hydroxytryptophan=tryptophan.
Serotonin, a potent constrictor of cerebral arteries (1 ) , is synthesized from dietary tryptophan, which is first hydroxylated to 5-hydroxytryptophan and then decarboxy lated. Wooley and Shaw (2) and Allen et al. 
Materials and Methods
Mongrel dogs of either sex, weighing 7 to 15 kg, were anesthetized with ip. injections of 50 mg/kg sodium pentobarbital and were sacrificed by bleeding from the common carotid arteries. The brain was rapidly removed, and basilar and middle cerebral arteries (0.7 to 0.8 mm outside diameter) were isolated. Distal portions of the femoral and mesenteric arteries (0.7 to 0.8 mm) were also isolated. The arteries were cut helically into strips, approximately 20 mm long. The strips were vertically fixed between hooks under a resting tension of 1.5 g (11 ) in a muscle bath containing the nutrient solution, which was aerated with a mixture of 95%02 and 5% C02 and was maintained at 37--1-0.5'C. The hook anchoring the upper end of the strips was connected to the lever of a force displacement transducer (Nihonkoden Kogyo Co., Tokyo Modification by antagonists of the re sponses to serotonin and tryptarnine:
In cerebral arterial strips, the dose-response curve for serotonin was shifted to the right and downward by treatment with cinanserin in concentrations of 3x10-11, 10-7 and 10-6 M (Fig. 2, left) , while the curve in femoral and mesenteric arteries was shifted to the right (Fig. 2, middle and right) . Cinanserin alone did not alter the tension. Average pA2 values for femoral and mesenteric arteries were 7.96 and 8.38, respectively, and the slopes of the regression line were -1.02 and -0.88, respectively.
Treatment of femoral arteries with methysergide (10-11, 10-' and 10-6 M) shifted the dose-response curve for serotonin to the right; the pA2 value was 8.21, and the slope of the line was -0.98. Methysergide alone did not alter the tension of femoral arteries.
Contractions of cerebral arteries induced by serotonin in concentrations up to 2x10-6 M, and relaxations seen in concentrations higher than 10-5 M were not significantly influenced by 10-6 M propranolol (N=4), 10-6 M atropine (N=3), 2 X 10-5 M aminophylline (N=3) and 5X10-5 M aspirin (N=3).
In helical strips of cerebral arteries, treat ment with 10-7 M cinanserin did not sig nificantly alter the response to tryptamine; however, increase in concentrations of cinanserin to 10-6 and 10-5 M shifted the dose-response curve to the right (Fig. 3,  left) . The KB value estimated from the results with 10-5 M cinanserin was 6.3x10-7 M. Treatment of femoral arteries with 10-6 M cinanserin slightly attenuated the contractile response to tryptamine only in low concen trations (2x10-6 and 10-5M). Increase in the concentration of cinanserin to 10-5 M shifted the dose-response curve for tryptamine to the right (Fig. 3, right) ; the KB value was 6.8X10-6 M. Cinanserin (10-6 and 10-5 M) did not alter the contractile response to prostaglandin F2a of femoral (N=4) and cerebral arteries (N=3).
Treatment for 20 min with 10-7 M phen tolamine did not influence the contraction induced by serotonin in cerebral and femoral arteries nor the response of cerebral arteries to tryptamine (Fig. 4, left) . In contrast, phen tolamine (10-7 M) shifted the dose-response curve for tryptamine to the right in femoral (Fig. 4, right) 
Discussion
The potency for inducing contractions of helical strips of isolated dog cerebral arteries was in the order of serotonin>tryptamine , /5-hydroxytryptophan=tryptophan. Con tractions of cerebral arteries induced by kynurenamine were also less than those induced by its 5-hydroxy analogue (4). 5-Hydroxylation of the indole ring appears to play a significant role in raising the contractile potency. Both 5-hydroxytryptophan and tryptophan, having a carboxyl group in the ethylamine side chain, showed only a weak agonistic action; 5-hydroxyindoleacetic acid, in which the ethylamine side chain in serotonin is substituted with acetic acid, did not show serotonin-like actions (13). The acidic group in the side chain appears to diminish the action on serotonergic receptors, whereas the hydroxy group in the side chain such as that in 5-hydroxytryptophol (14) retains the ability to contract the arteries.
Treatment
of cerebral arteries with cin anserin attenuated the contractile response to serotonin in a dose-related manner as did methysergide, ergotamine and LSD (8), but it did not influence contractions induced by prostaglandin Fla. The dose-response curve for serotonin was shifted to the right and downward by these antagonists. The lack of a parallel shift in cerebral arteries may be due to the relaxant effect of serotonin in high concentrations ( Fig. 1, left In contrast to the data on cerebral arteries, dose-response curves for serotonin in femoral and mesenteric arteries were shifted to the right by cinanserin and methysergide. Slopes of the regression line of log [dose ratio -1] against log dose of the antagonists were roughly 1. These findings suggest that the antagonism is competitive. Similar results were obtained in the isolated external maxillary and lingual arteries of cats (9). The pA2 value of methysergide in dog femoral arteries (8.21) was consistent with the value (8.21 ) in external maxillary and lingual arteries (9).
The dose-response curve for tryptamine in cerebral arteries was shifted to the right by cinanserin. Tryptamine did not produce re laxations, even when the concentration was raised to 2x10-4M. Treatment with phentol amine did not alter the response to tryptamine. It seems likely that cinanserin competitively antagonizes the action of tryptamine on receptors which mediate the cerebroarterial contraction. There is evidence that receptors for serotonin and tryptamine may be either different or at least differentially accessible (19). This hypothesis is supported by the different ability of cinanserin to antagonize the responses to serotonin (Fig. 2, middle) and tryptamine (Fig. 3, right) in femoral arteries.
In femoral arterial strips, contractions induced by tryptamine were attenuated only slightly by cinanserin, the attenuation being approximately 1/10 that seen in cerebral arteries, but were moderately reduced by 10-' M phentolamine. The tryptamine induced contraction was not influenced by cocaine in concentrations sufficient to sup press the arterial response to nicotine and tyramine (20, 21) and also not influenced by bretylium in concentrations sufficient to suppress the response to transmural sym pathetic nerve stimulation (22). These findings lead us to conclude that tryptamine appears to act directly on a-adrenoceptors and to a lesser extent on tryptamine receptors. Dog cerebral arteries respond to norepin ephrine with only a slight contraction (1, 
